leisure time -WSS

leisure time

author：explore 2025-09-14 18:24:50 - browse：14

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： J&J reports mixed data on next

focus

leisure time

WSS

New research sheds light on how often breast cancer is overdiagnosed

Stroke rates rising, especially in working

Why some fertility treatments produce more boy babies

The Bio Revolution is changing business and society

Biden targets hefty hospital 'facility fees' that often surprise patients

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

focus

leisure time

explore

Continuity nursing helped my family in our darkest PICU moments

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Bright Health sells Medicare Advantage business to Molina

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Wildfire smoke exposes gaps in outdoor worker protections

Why some fertility treatments produce more boy babies

Cancer drug shortages should be causing more outrage

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Duchenne breakthrough therapy leaves behind pioneering families

The U.S. needs a new definition of substance use “recovery”

leisure time

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Judge agrees to delay next hearing in Trump classified documents case

Congress: Prevent baby formula shortages by passing a new bill

Parents surprise family after baby discharged from NICU after 170 days

Guardant Health colon cancer test endorsed by FDA advisory panel

Guardant Health colon cancer test endorsed by FDA advisory panel

focus

entertainment

leisure time

hotspot